Patrick Barry

Patrick Barry

Patrick Barry is EVP & Chief Commercial Officer and he has responsibility for all commercial activities for the U.S. Branded Business at Endo, including strategy, new product planning, marketing, sales as well as managed care and patient access responsibilities. Patrick joined Endo in November 2016 as SVP, U.S. Branded Pharmaceuticals. Prior to joining Endo, he…

Read More

Leslie Baumann, MD

Leslie Baumann

Leslie Baumann, MD is internationally known for her contributions to the field of cosmetic dermatology. She founded the University of Miami Cosmetic Medicine and Research Institute in 1997- the first academic institute in the US dedicated to cosmetic dermatology. She served as Professor of Dermatology at the University of Miami, Miller School of Medicine until…

Read More

Stephen J. Ronan, MD, FACS

Stephen Ronan

Dr. Ronan is a board certified Plastic Surgeon with a focus on aesthetic surgery and technology development. Operating out of the fully accredited Blackhawk Surgery Center located within Blackhawk Plastic Surgery, Dr. Ronan has developed a thriving surgical practice of breast, body, face and hair transplantation. A significant portion of the practice is dedicated to…

Read More

Kevin Thornal

Kevin Thornal

Kevin Thornal joined Hologic in August 2014 as Vice President, Customer Experience, Field Service and Clinical Applications for the Breast and Skeletal Health division. He transitioned to Vice President, Breast and Skeletal Health for the Europe, Middle East and Africa region in early 2016, and was promoted to his current position in July 2017. Prior…

Read More

Melinda Haws, MD

Melinda Haws

I am a Board-certified plastic surgeon from Nashville, TN. I am an associate clinical professor from Vanderbilt University. I have a special interest in breast and body surgery.

Read More

Alexandra Wilkis Wilson

Alexandra Wilkis Wilson

Entrepreneur, Executive, Board Director, Investor, Advisor, Mentor, Author, Public Speaker. Alexandra is an innovator and a disruptor. She has established herself as a pioneer, leader, and dealmaker in digital commerce, retail, merchandising, sales, business development and marketing. She has a proven track record building and operating early stage, fast-growing consumer-facing businesses and creating powerful brands.…

Read More

Scott Durbin

Scott Durbin

Scott joined Viveve in early 2013 and became CEO in May 2018. He previously served as the company’s CFO. He is committed to leading Viveve’s clinical and commercial development of its CMRF technology to solidify its position as a global leader in women’s intimate health. Prior to Viveve, he was CFO of publicly traded Aastrom…

Read More

William Meury

William Meury

Since May 2016, Mr. Meury has served as the Chief Commercial Officer of Allergan, plc. Mr. Meury previously served as President, Branded Pharma from March 2015 to May 2016 and joined Allergan in July 2014 as Executive Vice President, Commercial, North American Brands. He has significant experience in launching and commercializing healthcare products. Prior to…

Read More

David Amsellem

David Amsellem

David Amsellem is a managing director and senior research analyst at Piper Jaffray covering specialty pharmaceuticals. Prior to joining Piper Jaffray in 2008, David spent five years at Friedman Billings Ramsey, where he was a senior research analyst covering small- and mid-cap pharmaceuticals from 2006-08 and a senior associate on the biotechnology equity research team…

Read More

Merz Americas’ CEO Bob Rhatigan Discusses Reclaimers, Toxin Commoditization, and Christie Brinkley

Bob Rhatigan AIP005 Podcast

In this Aesthetics Innovators Podcast Episode, Bob Rhatigan, CEO of Merz Americas, talks with co-host Grant Stevens, MD, about the battle building in the toxin market, including Merz’s own Xeomin. Is the risk of commoditization real? Rhatigan also discusses several of the company’s effective marketing plans to target “Reclaimers” and to tout the effectiveness of…

Read More